IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

KATIE GRANGER SWANTON

Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical

NPI
1952568909
CMS profile
1272531
Location
BEAUMONT, TX

General Payments · PY2021–2024

$1,520.82

  • Reported across 79 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,159.45

54 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Medical TX All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,159.45 54

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $400.47 21
Incyte Corporation $127.96 6
Amgen Inc. $100.18 5
Genentech USA, Inc. $93.91 1
GENZYME CORPORATION $86.47 4
NOVARTIS PHARMACEUTICALS CORPORATION $68.14 4
Takeda Pharmaceuticals U.S.A., Inc. $58.55 3
ABBVIE INC. $44.50 2
Kaleo, Inc. $40.90 2
Pharming Healthcare, Inc. $38.40 2
Regeneron Healthcare Solutions, Inc. $28.10 1
CSL Behring $24.84 1
X4 Pharmaceuticals, Inc. $24.81 1
LEO Pharma Inc. $22.22 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $361.37 25
PY2024 $1,159.45 54

Payment records · PY2024 (54)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2021 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $22.18 03/19/2024 Food and Beverage Undisputed 01/23/2026 1103829084 CMS
ABBVIE INC. $22.32 10/07/2024 Food and Beverage Undisputed 01/23/2026 1103829086 CMS
Amgen Inc. $20.14 02/29/2024 Food and Beverage Undisputed 01/23/2026 1117264911 CMS
Amgen Inc. $21.85 04/09/2024 Food and Beverage Undisputed 01/23/2026 1117264913 CMS
Amgen Inc. $19.79 07/11/2024 Food and Beverage Undisputed 01/23/2026 1117264915 CMS
Amgen Inc. $20.91 08/01/2024 Food and Beverage Undisputed 01/23/2026 1117264917 CMS
Amgen Inc. $17.49 10/21/2024 Food and Beverage Undisputed 01/23/2026 1117264919 CMS
AstraZeneca Pharmaceuticals LP $13.82 01/30/2024 Food and Beverage Undisputed 01/23/2026 1123302576 CMS
AstraZeneca Pharmaceuticals LP $14.50 02/20/2024 Food and Beverage Undisputed 01/23/2026 1123310758 CMS
AstraZeneca Pharmaceuticals LP $17.26 03/07/2024 Food and Beverage Undisputed 01/23/2026 1123310086 CMS
AstraZeneca Pharmaceuticals LP $30.60 03/20/2024 Food and Beverage Undisputed 01/23/2026 1123310518 CMS
AstraZeneca Pharmaceuticals LP $19.55 04/16/2024 Food and Beverage Undisputed 01/23/2026 1123304218 CMS
AstraZeneca Pharmaceuticals LP $17.33 05/01/2024 Food and Beverage Undisputed 01/23/2026 1123305860 CMS
AstraZeneca Pharmaceuticals LP $16.56 05/07/2024 Food and Beverage Undisputed 01/23/2026 1123307354 CMS
AstraZeneca Pharmaceuticals LP $18.98 07/02/2024 Food and Beverage Undisputed 01/23/2026 1123308942 CMS
AstraZeneca Pharmaceuticals LP $18.31 08/05/2024 Food and Beverage Undisputed 01/23/2026 1123312002 CMS
AstraZeneca Pharmaceuticals LP $17.68 08/13/2024 Food and Beverage Undisputed 01/23/2026 1123306726 CMS
AstraZeneca Pharmaceuticals LP $16.87 08/21/2024 Food and Beverage Undisputed 01/23/2026 1123305774 CMS
AstraZeneca Pharmaceuticals LP $19.99 08/27/2024 Food and Beverage Undisputed 01/23/2026 1123311516 CMS
AstraZeneca Pharmaceuticals LP $29.43 09/05/2024 Food and Beverage Undisputed 01/23/2026 1123307906 CMS
AstraZeneca Pharmaceuticals LP $19.07 09/10/2024 Food and Beverage Undisputed 01/23/2026 1123310110 CMS
AstraZeneca Pharmaceuticals LP $18.75 09/12/2024 Food and Beverage Undisputed 01/23/2026 1123305942 CMS
AstraZeneca Pharmaceuticals LP $13.30 10/10/2024 Food and Beverage Undisputed 01/23/2026 1123308700 CMS
AstraZeneca Pharmaceuticals LP $19.39 10/15/2024 Food and Beverage Undisputed 01/23/2026 1123305474 CMS
AstraZeneca Pharmaceuticals LP $19.21 11/13/2024 Food and Beverage Undisputed 01/23/2026 1123308712 CMS
AstraZeneca Pharmaceuticals LP $21.16 12/03/2024 Food and Beverage Undisputed 01/23/2026 1123308578 CMS
AstraZeneca Pharmaceuticals LP $18.47 12/06/2024 Food and Beverage Undisputed 01/23/2026 1123311734 CMS
AstraZeneca Pharmaceuticals LP $20.24 12/20/2024 Food and Beverage Undisputed 01/23/2026 1123306846 CMS
CSL Behring $24.84 05/01/2024 Food and Beverage Undisputed 01/23/2026 1134636721 CMS
Genentech USA, Inc. $93.91 10/16/2024 Food and Beverage Undisputed 01/23/2026 1133167248 CMS
GENZYME CORPORATION $16.11 01/25/2024 Food and Beverage Undisputed 01/23/2026 1139901676 CMS
GENZYME CORPORATION $25.96 04/02/2024 Food and Beverage Undisputed 01/23/2026 1139901680 CMS
GENZYME CORPORATION $15.13 05/29/2024 Food and Beverage Undisputed 01/23/2026 1139901738 CMS
GENZYME CORPORATION $29.27 07/16/2024 Food and Beverage Undisputed 01/23/2026 1139901746 CMS
Incyte Corporation $19.99 04/04/2024 Food and Beverage Undisputed 01/23/2026 1141170699 CMS
Incyte Corporation $24.78 07/18/2024 Food and Beverage Undisputed 01/23/2026 1141170749 CMS
Incyte Corporation $21.46 08/20/2024 Food and Beverage Undisputed 01/23/2026 1141170751 CMS
Incyte Corporation $24.28 10/17/2024 Food and Beverage Undisputed 01/23/2026 1141170701 CMS
Incyte Corporation $16.72 11/14/2024 Food and Beverage Undisputed 01/23/2026 1141170703 CMS
Incyte Corporation $20.73 12/17/2024 Food and Beverage Undisputed 01/23/2026 1141170745 CMS
kaleo, Inc. $20.62 02/06/2024 Food and Beverage Undisputed 01/23/2026 1126633205 CMS
kaleo, Inc. $20.28 06/18/2024 Food and Beverage Undisputed 01/23/2026 1126633207 CMS
LEO Pharma Inc. $22.22 01/23/2024 Food and Beverage Undisputed 01/23/2026 1152669597 CMS
Novartis Pharmaceuticals Corporation $17.60 04/22/2024 Food and Beverage Undisputed 01/23/2026 1086947649 CMS
Novartis Pharmaceuticals Corporation $14.69 05/30/2024 Food and Beverage Undisputed 01/23/2026 1086947627 CMS
Novartis Pharmaceuticals Corporation $21.48 08/08/2024 Food and Beverage Undisputed 01/23/2026 1086947633 CMS
Novartis Pharmaceuticals Corporation $14.37 11/14/2024 Food and Beverage Undisputed 01/23/2026 1086947645 CMS
Pharming Healthcare, Inc. $17.39 10/22/2024 Food and Beverage Undisputed 01/23/2026 1132176772 CMS
Pharming Healthcare, Inc. $21.01 11/21/2024 Food and Beverage Undisputed 01/23/2026 1132176777 CMS
Regeneron Healthcare Solutions, Inc. $28.10 09/30/2024 Food and Beverage Undisputed 01/23/2026 1114308347 CMS
Takeda Pharmaceuticals U.S.A., Inc. $14.89 02/05/2024 Food and Beverage Undisputed 01/23/2026 1137755422 CMS
Takeda Pharmaceuticals U.S.A., Inc. $19.53 09/03/2024 Food and Beverage Undisputed 01/23/2026 1137755424 CMS
Takeda Pharmaceuticals U.S.A., Inc. $24.13 10/31/2024 Food and Beverage Undisputed 01/23/2026 1137755426 CMS
X4 Pharmaceuticals, Inc. $24.81 11/07/2024 Food and Beverage Undisputed 01/23/2026 1147391096 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.